Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

NCT01838512

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution Birmingham, Alabama, United States
  • Local Institute Goodyear, Arizona, United States
  • Local Institution - 0023 Anaheim, California, United States
  • Local Institution Anaheim, California, United States
View all 130 locations
View Trial Details
Active, not recruiting

A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma

NCT04174196

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack Commack, New York, United States
View Trial Details
Active, not recruiting

PTLD: Multicentric Retrospective Study

NCT06422715

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +3 more
Locations
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Ematologia Milan, MI, Italy
  • Centro Di Riferimento Oncologico Di Aviano, S.O.C. Oncologia Medica e dei Tumori Immunocorrelati Aviano, Italy
  • Azienda Ospedaliera Papa Giovanni XXIII - Ematologia Bergamo, Italy
  • A.O. UNIVERSITARIA POLICLINICO S.ORSOLA-MALPIGHI DI BOLOGNA - Istituto di Ematologia "Seragnoli" Bologna, Italy
View all 21 locations
View Trial Details
Active, not recruiting

Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma

NCT04091126

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Westwood, Kansas, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Madison, Wisconsin, United States
  • GSK Investigational Site Newcastle, New South Wales, Australia
View all 30 locations
View Trial Details
Active, not recruiting

Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT02570542

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow up Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow Up Only) Montvale, New Jersey, United States
View all 14 locations
View Trial Details

Related conditions